Blogs / SBI to Raise ₹20,000...

SBI to Raise ₹20,000 Crore via Bonds in FY26

2025-07-16 · 5 min

Sector - Finance
SBI to Raise ₹20,000 Crore via Bonds in FY26

SBI’s ₹20,000 Crore Bond Plan: A Strategic Capital Move

On July 16, 2025, the State Bank of India (SBI) — India’s largest public sector bank — approved plans to raise up to ₹20,000 crore during FY26 through Basel III-compliant Additional Tier 1 (AT1) and Tier II bonds.

These bonds will be issued in Indian rupees (INR) and offered to domestic investors, reinforcing SBI’s confidence in India’s bond markets and long-term liquidity.


Why SBI Is Raising Funds

SBI is already financially strong, but this move helps:

  •  Strengthen its capital adequacy ratio (CAR) beyond current levels (14.25%)

  • Meet Basel III norms set by the RBI and global regulators

  • Support future credit growth across retail, SME, and infrastructure sectors

  • Replace maturing bonds and maintain balance sheet stability

This isn’t a bailout — it’s a forward-looking strategy to build resilience.


What Are AT1 and Tier II Bonds?

  • AT1 Bonds: Perpetual, higher yield (~8%), higher risk

  • Tier II Bonds: Long-term (typically 10–15 years), safer, ~7.3–7.5% return

Both instruments help SBI maintain required regulatory capital while offering attractive investment opportunities to institutions.


 Market Reaction and Investor Impact

Following the announcement, SBI’s stock rose nearly 2%, signaling strong investor confidence.

For investors:

  • Mutual funds, insurers, and pension funds may benefit from secure returns

  • Retail and HNI investors may access these bonds through secondary markets or debt platforms

The move may set a trend for other public sector banks planning bond issues in FY26


Key Takeaways

  • SBI’s ₹20,000 crore bond issue is India’s largest capital raise this fiscal by a PSU bank

  • Strengthens India’s banking system, boosts lending capacity, and supports economic growth

  • Sends a message of stability and discipline to global and domestic investors


To read the RA disclaimer, please click here